The value of miRNA in diagnosing thyroid cancer: A systematic review

Cancer Biomarkers

Volumn 11, Issue 6, 2012, Pages 229-238

  Lodewijk, L ^a   Prins, A M ^a   Kist, J W ^a   Valk, G D ^a   Kranenburg, O ^a   Rinkes, I H M Borel ^a   Vriens, M R ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

cancer; diagnostic value; FNA; miRNA; nodules; review; thyroid

Indexed keywords

DNA; MICRORNA; MICRORNA 146; MICRORNA 155; MICRORNA 181; MICRORNA 181A; MICRORNA 181C; MICRORNA 21; MICRORNA 220; MICRORNA 221; MICRORNA 222; UNCLASSIFIED DRUG;

ANAPLASTIC THYROID CANCER; DNA DAMAGE; DOWN REGULATION; FINE NEEDLE ASPIRATION BIOPSY; FORMALIN FIXED PARAFFIN EMBEDDED TISSUE; FRESH FROZEN TISSUE; FROZEN SECTION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TISSUE MICROARRAY; TISSUE PRESERVATION; UPREGULATION;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; THYROID NEOPLASMS;

EID: 84871548427     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2012-0273     Document Type: Review

References (66)

1. D. Abraham, N. Jackson, J.S. Gundara, J. Zhao, A.J. Gill, L. Delbridge, B.G. Robinson, S.B. Sidhu, MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets. Clin Cancer Res 17 (2011) 4772-4781.
2. B. Aschebrook-Kilfoy, M.H.Ward, M.M. Sabra, S.S. Devesa, Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid 21 (2011) 125-134.
3. Z.W. Baloch, V.A. LiVolsi, S.L. Asa, J. Rosai, M.J. Merino, G. Randolph, P. Vielh, R.M. DeMay, M.K. Sidawy, W.J. Frable, Diagnostic terminology andmorphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 36 (2008) 425-437. (Pubitemid 351829800)
4. D.P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297.
5. J. Braun, C. Hoang-Vu, H. Dralle, S. Huttelmaier, Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene 29 (2010) 4237-4244.
6. J. Braun, S. Huttelmaier, Pathogenic mechanisms of deregulated microRNA expression in thyroid carcinomas of follicular origin. Thyroid research 4 Suppl 1 (2011) S1.
7. P. Brest, S. Lassalle, V. Hofman, O. Bordone, V.G. Tanga, C. Bonnetaud, C. Moreilhon, G. Rios, J. Santini, P. Barbry, C. Svanborg, B. Mograbi, B. Mari, P. Hofman, MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells. Endocr Relat Cancer 18 (2011) 711-719.
8. S. Cahill, P. Smyth, K. Denning, R. Flavin, J. Li, A. Potratz, S.M. Guenther, R. Henfrey, J.J. O'Leary, O. Sheils, Effect of BRAFV600E mutation on transcription and posttranscriptional regulation in a papillary thyroid carcinoma model. Molecular Cancer 6 (2007).
9. S. Cahill, P. Smyth, S.P. Finn, K. Denning, R. Flavin, E.M. O'Regan, J. Li, A. Potratz, S.M. Guenther, R. Henfrey, J.J. O'Leary, O. Sheils, Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model. Molecular Cancer 5 (2006).
10. S. Cantara, M. Capezzone, S. Marchisotta, S. Capuano, G. Busonero, P. Toti, A. Di Santo, G. Caruso, A.F. Carli, L. Brilli, A. Montanaro, F. Pacini, Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab 95 (2010) 1365-1369.
11. Y.T. Chen, N. Kitabayashi, X.K. Zhou, T.J. Fahey, 3rd, T. Scognamiglio, MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod Pathol 21 (2008) 1139-1146.
12. L. Dal Maso, M. Lise, P. Zambon, F. Falcini, E. Crocetti, D. Serraino, C. Cirilli, R. Zanetti, M. Vercelli, S. Ferretti, F. Stracci, V. De Lisi, S. Busco, G. Tagliabue, M. Budroni, R. Tumino, A. Giacomin, S. Franceschi, A.W. Group, Incidence of thyroid cancer in Italy, 1991-2005: time trends and ageperiod-cohort effects. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO 22 (2011) 957-963.
13. V.C. Daniel, L. Marchionni, J.S. Hierman, J.T. Rhodes, W.L. Devereux, C.M. Rudin, R. Yung, G. Parmigiani, M. Dorsch, C.D. Peacock, D.N. Watkins, A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res 69 (2009) 3364-3373.
14. L. Davies, H.G.Welch, Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA: The journal of the American Medical Association 295 (2006) 2164-2167.
15. A. De La Chapelle, K. Jazdzewski, MicroRNAs in thyroid cancer. Journal of Clinical Endocrinology and Metabolism 96 (2011) 3326-3336.
16. I. dos Santos Silva, A.J. Swerdlow, Thyroid cancer epidemiology in England and Wales: Time trends and geographical distribution. Br J Cancer 67 (1993) 330-340. (Pubitemid 23049558)
17. M. Eszlinger, R. Paschke, Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Molecular and cellular endocrinology 322 (2010) 29-37.
18. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, D.M. Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer. Journal international du cancer 127 (2010) 2893-2917.
19. C. Ferraz, M. Eszlinger, R. Paschke, Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. J Clin Endocrinol Metab 96 (2011) 2016-2026.
20. M.V. Geraldo, A.S.Yamashita, E.T.Kimura, MicroRNA miR-146b-5p regulates signal transduction of TGF-[beta] by repressingSMAD4in thyroid cancer.Oncogene 31 (2012) 1910-1922.
21. H. He, K. Jazdzewski, W. Li, S. Liyanarachchi, R. Nagy, S. Volinia, G.A. Calin, C.G. Liu, K. Franssila, S. Suster, R.T. Kloos, C.M. Croce, A. de la Chapelle, The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102 (2005) 19075-19080. (Pubitemid 43049568)
22. A. Hui, C. How, E. Ito, F.F. Liu, Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies. BMC Cancer 11 (2011) 500.
23. X.M. Keutgen, F. Filicori, M.J. Crowley, Y. Wang, T. Scognamiglio, R. Hoda, D. Buitrago, D. Cooper, M.A. Zeiger, R. Zarnegar, O. Elemento, T.J. Fahey, 3rd, A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Clin Cancer Res 18 (2012) 2032-2038.
24. H.J. Kim, J.K. Chung, W. Hwang do, D.S. Lee, S. Kim, In vivo imaging of miR-221 biogenesis in papillary thyroid carcinoma. Molecular imaging and biology: MIB: the official publication of the Academy of Molecular Imaging 11 (2009) 71-78.
25. M. Kitano, R. Rahbari, E.E. Patterson, S.M. Steinberg, N.B. Prasad, Y.Wang,M.A. Zeiger, E.Kebebew, Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples. Thyroid 22 (2012) 285-291.
26. M. Kitano, R. Rahbari, E.E. Patterson, Y. Xiong, N.B. Prasad, Y. Wang, M.A. Zeiger, E. Kebebew, Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs. Ann Surg Oncol 18 (2011) 3443-3452.
27. T. Kondo, S. Ezzat, S.L. Asa, Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6 (2006) 292-306.
28. M. Korpal, E.S. Lee, G. Hu, Y. Kang, The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. The Journal of biological chemistry 283 (2008) 14910-14914.
29. C.L. Kosary, Cancer of the thyroid. In: Ries LAG, Young JL, Keel GE, EisnerMP, LinYD, HornerM-J (eds) SEERsurvival monograph: cancer survival among adults: U.S. SEER program, 1988-2001, patient and tumor characteristics. National Cancer Institute, SEER Program, Bethesda, MD. NIH Pub. No. 07-6215.Available at: http://seer.cancer.gov/publications/survival/surv thyroid.pdf. (2007).
30. L.J. Layfield, J. Abrams, B. Cochand-Priollet, D. Evans, H. Gharib, F. Greenspan, M. Henry, V. LiVolsi, M. Merino, C.W. Michael, H. Wang, S.A. Wells, Post-thyroid FNA testing and treatment options: A synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn Cytopathol 36 (2008) 442-448. (Pubitemid 351829802)
31. J.I. Lew, R.A. Snyder, Y.M. Sanchez, C.C. Solorzano, Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients. Journal of the American College of Surgeons 213 (2011) 188-194.
32. H. Mazeh, MicroRNA as a Diagnostic Tool in Fine-Needle Aspiration Biopsy of ThyroidNodules. The oncologist (2012).
33. H. Mazeh, I. Mizrahi, D. Halle, N. Ilyayev, A. Stojadinovic, B. Trink, S. Mitrani-Rosenbaum, M. Roistacher, I. Ariel, A. Eid, H.R. Freund, A. Nissan, Development of a microRNAbased molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples. Thyroid 21 (2011) 111-118.
34. F. Megiorni, A. Pizzuti, L. Frati, Clinical Significance of MicroRNAExpression Profiles and Polymorphisms in Lung Cancer Development and Management. Pathology research international 2011 (2011) 780652.
35. C. Mian, G. Pennelli, M. Fassan, M. Balistreri, S. Barollo, E. Cavedon, F. Galuppini, M. Pizzi, F. Vianello, M.R. Pelizzo, M. Girelli, M. Rugge, G. Opocher, microRNA profiles in familial and sporadic medullary thyroid carcinoma: Preliminary relationships with RET status and outcome. Thyroid (2012).
36. S.Mitomo, C.Maesawa, S. Ogasawara, T. Iwaya,M. Shibazaki, A. Yashima-Abo, K. Kotani, H. Oikawa, E. Sakurai, N. Izutsu, K. Kato, H. Komatsu, K. Ikeda, G. Wakabayashi, T. Masuda, Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Science 99 (2008) 280-286. (Pubitemid 351228481)
37. W. Moses, J.Weng, I. Sansano, M. Peng, E. Khanafshar, B.M. Ljung, Q.Y. Duh, O.H. Clark, E. Kebebew, Molecular testing for somatic mutations improves the accuracy of thyroid fineneedle aspiration biopsy. World J Surg 34 (2010) 2589-2594.
38. Y.E. Nikiforov, M.N. Nikiforova, Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol 7 (2011) 569-580.
39. Y.E. Nikiforov, N.P. Ohori, S.P. Hodak, S.E. Carty, S.O. LeBeau, R.L. Ferris, L. Yip, R.R. Seethala, M.E. Tublin, M.T. Stang, C. Coyne, J.T. Johnson, A.F. Stewart, M.N. Nikiforova, Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: A prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 96 (2011) 3390-3397.
40. M.N. Nikiforova, RAS PointMutations and PAX8-PPARgamma Rearrangement in Thyroid Tumors: Evidence for Distinct Molecular Pathways in Thyroid Follicular Carcinoma. Journal of Clinical Endocrinology & Metabolism 88 (2003) 2318-2326. (Pubitemid 36549913)
41. M.N. Nikiforova, S.I. Chiosea, Y.E. Nikiforov, MicroRNA expression profiles in thyroid tumors. Endocr Pathol 20 (2009) 85-91.
42. M.N. Nikiforova, Y.E. Nikiforov, Molecular diagnostics and predictors in thyroid cancer. Thyroid 19 (2009) 1351-1361.
43. M.N. Nikiforova, G.C. Tseng, D. Steward, D. Diorio, Y.E. Nikiforov, MicroRNA expression profiling of thyroid tumors: Biological significance and diagnostic utility. J Clin Endocrinol Metab 93 (2008) 1600-1608. (Pubitemid 351656494)
44. M. Nugent, N. Miller, M.J. Kerin, MicroRNAs in colorectal cancer: Function, dysregulation and potential as novel biomarkers. European journal of surgical oncology: The journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 37 (2011) 649-654.
45. M. Osaki, F. Takeshita, T. Ochiya, MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers 13 (2008) 658-670.
46. P. Pallante, R. Visone, M. Ferracin, A. Ferraro, M.T. Berlingieri, G. Troncone, G. Chiappetta, C.G. Liu, M. Santoro, M. Negrini, C.M. Croce, A. Fusco, MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13 (2006) 497-508. (Pubitemid 43886672)
47. X. Pan, Z.-X. Wang, R. Wang, MicroRNA-21: A novel therapeutic target in human cancer. Cancer Biology and Therapy 10 (2010) 1224-1232.
48. F. Perri,G.D. Lorenzo, G.D. Scarpati, C. Buonerba, Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options. World journal of clinical oncology 2 (2011) 150-157.
49. S. Piana, A. Frasoldati, M. Ferrari, R. Valcavi, E. Froio, V. Barbieri, C. Pedroni, G. Gardini, Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18,000 FNAs reported at the same institution during 1998-2007. Cytopathology: Official journal of the British Society for Clinical Cytology 22 (2011) 164-173.
50. H.V. Reddi, P. Madde, D. Milosevic, J.S. Hackbarth, A. Algeciras-Schimnich, B. McIver, S.K. Grebe, N.L. Eberhardt, The Putative PAX8/PPARgamma Fusion Oncoprotein Exhibits Partial Tumor Suppressor Activity through Up-Regulation of Micro-RNA-122 and Dominant-Negative PPARgamma Activity. Genes Cancer 2 (2011) 46-55.
51. M. Rossing, R. Borup, R. Henao, O. Winther, J. Vikesaa, O. Niazi, C. Godballe, A. Krogdahl, M. Glud, C. Hjort-Sorensen, K. Kiss, F.N. Bennedbaek, F.C. Nielsen, Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma. J Mol Endocrinol 48 (2012) 11-23.
52. D. Rusinek, S. Szpak-Ulczok, B. Jarzab, Gene expression profile of human thyroid cancer in relation to its mutational status. J Mol Endocrinol (2011).
53. S. Schwertheim, S.Y. Sheu, K. Worm, F. Grabellus, K.W. Schmid, Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma. Horm Metab Res 41 (2009) 475-481.
54. R. Shen, S. Liyanarachchi, W. Li, P.E.Wakely, Jr., M. Saji, J. Huang, R. Nagy, T. Farrell, M.D. Ringel, A. de la Chapelle, R.T. Kloos, H. He, MicroRNA signature in thyroid fine needle aspiration cytology applied to "atypia of undetermined significance" cases. Thyroid 22 (2012) 9-16.
55. S.Y. Sheu, F. Grabellus, S. Schwertheim, K. Worm, M. Broecker-Preuss, K.W. Schmid, Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours. Br J Cancer 102 (2010) 376-382.
56. S. Takakura, N. Mitsutake, M. Nakashima, H. Namba, V.A. Saenko, T.I. Rogounovitch, Y. Nakazawa, T. Hayashi, A. Ohtsuru, S. Yamashita, Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. Cancer Science 99 (2008) 1147-1154. (Pubitemid 351676626)
57. F. Talotta, A. Cimmino, M.R. Matarazzo, L. Casalino, G. De Vita, M. D'Esposito, R. Di Lauro, P. Verde, An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene 28 (2008) 73-84.
58. M.T. Tetzlaff, A. Liu, X. Xu, S.R.Master, D.A. Baldwin, J.W. Tobias, V.A. Livolsi, Z.W. Baloch, Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol 18 (2007) 163-173. (Pubitemid 351384379)
59. M. Todaro, F. Iovino, V. Eterno, P. Cammareri, G. Gambara, V. Espina, G. Gulotta, F. Dieli, S. Giordano, R. De Maria, G. Stassi, Tumorigenic and metastatic activity of human thyroid cancer stem cells. Cancer Res 70 (2010) 8874-8885.
60. R. Visone, P. Pallante, A. Vecchione, R. Cirombella, M. Ferracin, A. Ferraro, S. Volinia, S. Coluzzi, V. Leone, E. Borbone, C.G. Liu, F. Petrocca, G. Troncone, G.A. Calin, A. Scarpa, C. Colato, G. Tallini, M. Santoro, C.M. Croce, A. Fusco, Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26 (2007) 7590-7595. (Pubitemid 350207711)
61. R. Visone, L. Russo, P. Pallante, I. De Martino, A. Ferraro, V. Leone, E. Borbone, F. Petrocca, H.Alder, C.M. Croce, A. Fusco, MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 14 (2007) 791-798. (Pubitemid 350074067)
62. M.R. Vriens, J. Weng, I. Suh, N. Huynh, M.A. Guerrero, W.T. Shen, Q.Y. Duh, O.H. Clark, E. Kebebew, MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer. Cancer 118 (2012) 3426-3432.
63. F. Weber, R.E. Teresi, C.E. Broelsch, A. Frilling, C. Eng, A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. J Clin Endocrinol Metab 91 (2006) 3584-3591. (Pubitemid 44402141)
64. L. Yip, L. Kelly, Y. Shuai, M.J. Armstrong, Y.E. Nikiforov, S.E. Carty, M.N. Nikiforova, MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. Ann Surg Oncol 18 (2011) 2035-2041.
65. B. Zhang, X. Pan, G.P. Cobb, T.A. Anderson, microRNAs as oncogenes and tumor suppressors. Developmental biology 302 (2007) 1-12. (Pubitemid 46096921)
66. X. Zhang, J. Chen, T. Radcliffe, D.P. Lebrun, V.A. Tron, H. Feilotter, An array-based analysis of microRNA expression comparing matched frozen and formalin-fixed paraffinembedded human tissue samples. J Mol Diagn 10 (2008) 513-519.